Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia

BackgroundCongenital heart disease (CHD) patients are thought to be vulnerable to COVID-19 complications. In this study, we would like to assess the outcomes and clinical characteristics in COVID-19 CHD patients.MethodA single-center, observational study was conducted in National Cardiovascular Cent...

Full description

Bibliographic Details
Main Authors: Sisca Natalia Siagian, Susandy Oetama, Fathy Zuandi Pohan, Brian Mendel, Olfi Lelya, Damba Dwisepto Aulia Sakti, Yovi Kurniawati
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1022183/full
_version_ 1811192167099531264
author Sisca Natalia Siagian
Susandy Oetama
Fathy Zuandi Pohan
Brian Mendel
Brian Mendel
Olfi Lelya
Damba Dwisepto Aulia Sakti
Yovi Kurniawati
author_facet Sisca Natalia Siagian
Susandy Oetama
Fathy Zuandi Pohan
Brian Mendel
Brian Mendel
Olfi Lelya
Damba Dwisepto Aulia Sakti
Yovi Kurniawati
author_sort Sisca Natalia Siagian
collection DOAJ
description BackgroundCongenital heart disease (CHD) patients are thought to be vulnerable to COVID-19 complications. In this study, we would like to assess the outcomes and clinical characteristics in COVID-19 CHD patients.MethodA single-center, observational study was conducted in National Cardiovascular Center Harapan Kita (NCCHK). This study included patients with CHD who were hospitalized for COVID-19. The extracted data were baseline characteristics, clinical findings, supportive examination findings, complications, outcomes, and length of stay of the patients. The data were then analyzed using SPSS 26.0 software.ResultTwenty-six patients with CHD and COVID-19 infection were included in our study. There were 24 resolved cases and 2 deaths, four patients experienced complications such as renal insufficiency (1), sepsis (2), and multiorgan failure (1). The median length of stay was 13 days. The most common symptoms experienced by the patients were breathlessness (65.4%), cough (57.7%), and fever (42.3%).ConclusionWe observed a relatively mild COVID-19 clinical course despite prior research showing that patients with cardiovascular comorbidities, such as CHD, have a higher case-fatality rate. This could be because of the smaller sample size, non-standardized diagnosis, severity, treatment, and age group.
first_indexed 2024-04-11T23:48:17Z
format Article
id doaj.art-0b34eefbcef342cb83c9411d9db78903
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T23:48:17Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-0b34eefbcef342cb83c9411d9db789032022-12-22T03:56:34ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-11-01910.3389/fcvm.2022.10221831022183Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in IndonesiaSisca Natalia Siagian0Susandy Oetama1Fathy Zuandi Pohan2Brian Mendel3Brian Mendel4Olfi Lelya5Damba Dwisepto Aulia Sakti6Yovi Kurniawati7Division of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, IndonesiaDivision of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, IndonesiaDivision of Pediatric Cardiac Intensive Care, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, IndonesiaDivision of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, IndonesiaSultan Sulaiman Government Hospital, Serdang Bedagai, IndonesiaDivision of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, IndonesiaDivision of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, IndonesiaDivision of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Universitas Indonesia, Jakarta, IndonesiaBackgroundCongenital heart disease (CHD) patients are thought to be vulnerable to COVID-19 complications. In this study, we would like to assess the outcomes and clinical characteristics in COVID-19 CHD patients.MethodA single-center, observational study was conducted in National Cardiovascular Center Harapan Kita (NCCHK). This study included patients with CHD who were hospitalized for COVID-19. The extracted data were baseline characteristics, clinical findings, supportive examination findings, complications, outcomes, and length of stay of the patients. The data were then analyzed using SPSS 26.0 software.ResultTwenty-six patients with CHD and COVID-19 infection were included in our study. There were 24 resolved cases and 2 deaths, four patients experienced complications such as renal insufficiency (1), sepsis (2), and multiorgan failure (1). The median length of stay was 13 days. The most common symptoms experienced by the patients were breathlessness (65.4%), cough (57.7%), and fever (42.3%).ConclusionWe observed a relatively mild COVID-19 clinical course despite prior research showing that patients with cardiovascular comorbidities, such as CHD, have a higher case-fatality rate. This could be because of the smaller sample size, non-standardized diagnosis, severity, treatment, and age group.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1022183/fullclinical outcomecongenital heart diseaseCHD (congenital heart disease)COVID-19comorbidities
spellingShingle Sisca Natalia Siagian
Susandy Oetama
Fathy Zuandi Pohan
Brian Mendel
Brian Mendel
Olfi Lelya
Damba Dwisepto Aulia Sakti
Yovi Kurniawati
Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
Frontiers in Cardiovascular Medicine
clinical outcome
congenital heart disease
CHD (congenital heart disease)
COVID-19
comorbidities
title Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
title_full Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
title_fullStr Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
title_full_unstemmed Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
title_short Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
title_sort clinical outcomes of covid 19 infection in congenital heart disease a single center experience in indonesia
topic clinical outcome
congenital heart disease
CHD (congenital heart disease)
COVID-19
comorbidities
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1022183/full
work_keys_str_mv AT siscanataliasiagian clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia
AT susandyoetama clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia
AT fathyzuandipohan clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia
AT brianmendel clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia
AT brianmendel clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia
AT olfilelya clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia
AT dambadwiseptoauliasakti clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia
AT yovikurniawati clinicaloutcomesofcovid19infectionincongenitalheartdiseaseasinglecenterexperienceinindonesia